European Medicines Agency: Interactive map provides information on studies
The European Medicines Agency provides an interactive map with data from the information system for clinical trials. This is ...
Which critical medicines are in short supply in the European Union?
The drug shortages are the result of manufacturing problems, increased demand, and other issues. View on euronews ...
GlobalData on MSN4d
Unsafe and unregulated cell therapies being sold in Europe
The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...
Posts falsely claim Pfizer published list of Covid-19 vaccine side effects
Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...
The Pharma Letter4d
EMA annual report 2024
At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...
5 takeaways on the Critical Medicines Act
From funding challenges to what changes in joint drug procurement: Here’s what you need to know about the new rules aimed at ...
RFK Jr. Says Vaccinating Birds Against Avian Flu Will Create ‘Mutation Factories’
Robert F. Kennedy Jr. addressed the worsening avian flu crisis, saying vaccinating birds turns them into “mutation factories.
Protalix BioTherapeutics Says With Debt Fully Repaid, It's Well-Positioned To Execute Strategy Through 2025 And Beyond
Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start a Phase 2 trial for PRX-115 in 2025.
Eli Lilly (NYSE:LLY) Sees 1.59% Rise As Jaypirca Secures Positive EU Opinion
Eli Lilly (NYSE:LLY) recently announced several significant events, including promising trial results for baricitinib in ...
PharmaTimes5d
Rxulti approved in the European Union for adolescent schizophrenia
Otsuka Pharmaceutical Europe and Lundbeck have announced that the European Commission has approved Rxulti (brexpiprazole) for ...